BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siddiqui A, Ancha H, Tedesco D, Lightfoot S, Stewart CA, Harty RF. Antioxidant therapy with N-acetylcysteine plus mesalamine accelerates mucosal healing in a rodent model of colitis. Dig Dis Sci 2006;51:698-705. [PMID: 16614991 DOI: 10.1007/s10620-006-3194-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Kushkevych I, Jampílek J. Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis. Probiotics in the Prevention and Management of Human Diseases 2022. [DOI: 10.1016/b978-0-12-823733-5.00016-7] [Reference Citation Analysis]
2 Lee H, Lee JS, Cho HJ, Lee YJ, Kim ES, Kim SK, Nam TG, Jeong BS, Kim JA. Antioxidant Analogue 6-Amino-2,4,5-Trimethylpyridin-3-ol Ameliorates Experimental Colitis in Mice. Dig Dis Sci 2021;66:1022-33. [PMID: 32361923 DOI: 10.1007/s10620-020-06267-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Moura RM, Hartmann RM, Licks F, Schemitt EG, Colares JR, do Couto Soares M, Fillmann LS, Fillmann HS, Marroni NP. Antioxidant effect of mesalazine in the experimental colitis model induced by acetic acid. Journal of Coloproctology 2021;36:139-48. [DOI: 10.1016/j.jcol.2016.03.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
4 Masnadi Shirazi K, Sotoudeh S, Masnadi Shirazi A, Moaddab SY, Nourpanah Z, Nikniaz Z. Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial. Clin Res Hepatol Gastroenterol 2021;45:101532. [PMID: 33067169 DOI: 10.1016/j.clinre.2020.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
5 Yorulmaz E, Yorulmaz H, Gökmen ES, Altınay S, Küçük SH, Zengi O, Çelik DS, Şit D. Therapeutic effectiveness of rectally administered fish oil and mesalazine in trinitrobenzenesulfonic acid-induced colitis. Biomedicine & Pharmacotherapy 2019;118:109247. [DOI: 10.1016/j.biopha.2019.109247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Maurer LH, Cazarin CBB, Quatrin A, Minuzzi NM, Costa EL, Morari J, Velloso LA, Leal RF, Rodrigues E, Bochi VC, Júnior MRM, Emanuelli T. Grape peel powder promotes intestinal barrier homeostasis in acute TNBS-colitis: A major role for dietary fiber and fiber-bound polyphenols. Food Res Int 2019;123:425-39. [PMID: 31284994 DOI: 10.1016/j.foodres.2019.04.068] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
7 Singh AK, Hertzberger RY, Knaus UG. Hydrogen peroxide production by lactobacilli promotes epithelial restitution during colitis. Redox Biol. 2018;16:11-20. [PMID: 29471162 DOI: 10.1016/j.redox.2018.02.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
8 Parian AM, Mullin GE, Langhorst J, Brown AC. Inflammatory Bowel Disease. Integrative Medicine 2018. [DOI: 10.1016/b978-0-323-35868-2.00050-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Liu Y, Wang X, Hu CA. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease. Nutrients. 2017;9:pii: E920. [PMID: 28832517 DOI: 10.3390/nu9090920] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 12.7] [Reference Citation Analysis]
10 Matondo A, Kim SS. Targeted-mitochondria antioxidants therapeutic implications in inflammatory bowel disease. Journal of Drug Targeting 2018;26:1-8. [DOI: 10.1080/1061186x.2017.1339196] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Tian T, Wang Z, Zhang J. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies. Oxid Med Cell Longev 2017;2017:4535194. [PMID: 28744337 DOI: 10.1155/2017/4535194] [Cited by in Crossref: 213] [Cited by in F6Publishing: 246] [Article Influence: 35.5] [Reference Citation Analysis]
12 Chiu CT, Kuo SN, Hung SW, Yang CY. Combined Treatment with Hyaluronic Acid and Mesalamine Protects Rats from Inflammatory Bowel Disease Induced by Intracolonic Administration of Trinitrobenzenesulfonic Acid. Molecules 2017;22:E904. [PMID: 28556814 DOI: 10.3390/molecules22060904] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
13 Pereira SR, Pereira R, Figueiredo I, Freitas V, Dinis TC, Almeida LM. Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model. PLoS One. 2017;12:e0174116. [PMID: 28329021 DOI: 10.1371/journal.pone.0174116] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
14 Moura FA, Goulart MOF. Inflammatory Bowel Diseases. Gastrointestinal Tissue. Elsevier; 2017. pp. 99-112. [DOI: 10.1016/b978-0-12-805377-5.00007-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Kogure Y, Wang S, Tanaka K, Hao Y, Yamamoto S, Nishiyama N, Noguchi K, Dai Y. Elevated H2 O2 levels in trinitrobenzene sulfate-induced colitis rats contributes to visceral hyperalgesia through interaction with the transient receptor potential ankyrin 1 cation channel. J Gastroenterol Hepatol 2016;31:1147-53. [PMID: 26574143 DOI: 10.1111/jgh.13226] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
16 Moura FA, de Andrade KQ, Dos Santos JCF, Araújo ORP, Goulart MOF. Antioxidant therapy for treatment of inflammatory bowel disease: Does it work? Redox Biol 2015;6:617-39. [PMID: 26520808 DOI: 10.1016/j.redox.2015.10.006] [Cited by in Crossref: 216] [Cited by in F6Publishing: 222] [Article Influence: 27.0] [Reference Citation Analysis]
17 Pereira C, Grácio D, Teixeira JP, Magro F. Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease. Inflamm Bowel Dis 2015;21:2403-17. [PMID: 26193347 DOI: 10.1097/MIB.0000000000000506] [Cited by in Crossref: 40] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
18 Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol. 2015;3:62. [PMID: 26484345 DOI: 10.3389/fcell.2015.00062] [Cited by in Crossref: 124] [Cited by in F6Publishing: 129] [Article Influence: 15.5] [Reference Citation Analysis]
19 Cano-martínez D, Román ID, T. Lobo MV, Pastor O, Moreno-villena I, Paradela A, Hernández-breijo B, Fernández-moreno MD, Monserrat J, Sanmartín-salinas P, Gisbert JP, Guijarro LG. Effect of Infliximab in oxidised serum albumin levels during experimental colitis. Biomarkers 2014;19:693-701. [DOI: 10.3109/1354750x.2014.982189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
20 Xu M, Sun M, Qiao H, Ping Q, Elamin ES. Preparation and evaluation of colon adhesive pellets of 5-aminosalicylic acid. International Journal of Pharmaceutics 2014;468:165-71. [DOI: 10.1016/j.ijpharm.2014.04.040] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
21 Yum S, Park H, Hong S, Jeong S, Kim W, Jung Y. N-(2-Mercaptopropionyl)-glycine, a diffusible antioxidant, activates HIF-1 by inhibiting HIF prolyl hydroxylase-2: implication in amelioration of rat colitis by the antioxidant. Biochem Biophys Res Commun 2014;443:1008-13. [PMID: 24361888 DOI: 10.1016/j.bbrc.2013.12.081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
22 Wan YM, Zhu YQ, Yang JH, You LY, Yang J, Luo J. Therapeutic effect of a probiotic compound on TNBS-induced colitis in rats. Shijie Huaren Xiaohua Zazhi 2012; 20(1): 66-69 [DOI: 10.11569/wcjd.v20.i1.66] [Reference Citation Analysis]
23 Caltabiano C, Máximo FR, Spadari AP, da Conceição Miranda DD, Serra MM, Ribeiro ML, Martinez CA. 5-aminosalicylic acid (5-ASA) can reduce levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream. Dig Dis Sci 2011;56:1037-46. [PMID: 21042854 DOI: 10.1007/s10620-010-1378-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
24 Kim H, Huh J, Jeon H, Choi D, Han J, Kim Y, Jung Y. N,N'-Bis(5-aminosalicyl)-L-cystine is a potential colon-specific 5-aminosalicylic acid prodrug with dual therapeutic effects in experimental colitis. J Pharm Sci. 2009;98:159-168. [PMID: 18399548 DOI: 10.1002/jps.21404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
25 Ancha HR, Kurella RR, McKimmey CC, Lightfoot S, Harty RF. Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats. Dig Dis Sci 2009;54:758-66. [PMID: 18716872 DOI: 10.1007/s10620-008-0438-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
26 Rowan FE, Docherty NG, Coffey JC, O'Connell PR. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br J Surg 2009;96:151-8. [PMID: 19160346 DOI: 10.1002/bjs.6454] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 8.6] [Reference Citation Analysis]
27 Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni N, González-Gallego J, Tuñón MJ. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis 2008;14:1504-13. [PMID: 18623154 DOI: 10.1002/ibd.20543] [Cited by in Crossref: 89] [Cited by in F6Publishing: 89] [Article Influence: 5.9] [Reference Citation Analysis]
28 Ancha HR, Kurella RR, McKimmey CC, Lightfoot S, Harty RF. Luminal antioxidants enhance the effects of mesalamine in the treatment of chemically induced colitis in rats. Exp Biol Med (Maywood) 2008;233:1301-8. [PMID: 18703751 DOI: 10.3181/0805-RM-140] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
29 Guijarro LG, Mate J, Gisbert JP, Perez-Calle JL, Marín-Jimenez I, Arriaza E, Olleros T, Delgado M, Castillejo MS, Prieto-Merino D, Lara VG, Peña AS. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: Randomized, placebo-controlled pilot study. World J Gastroenterol 2008; 14(18): 2851-2857 [PMID: 18473409 DOI: 10.3748/wjg.14.2851] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
30 Aslan A, Temiz M, Hakverdi S, Polat G, Tumer C, Temiz A, Canbolant E. Effect of mesalamine on healing in experimental colon anastomosis: a randomised experimental study. Int J Surg. 2008;6:40-44. [PMID: 18088577 DOI: 10.1016/j.ijsu.2007.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
31 Sener G, Aksoy H, Sehirli O, Yüksel M, Aral C, Gedik N, Cetinel S, Yeğen BC. Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities. Dig Dis Sci 2007;52:2122-32. [PMID: 17431768 DOI: 10.1007/s10620-007-9801-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
32 Fillmann H, Kretzmann NA, San-Miguel B, Llesuy S, Marroni N, González-Gallego J, Tuñón MJ. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology 2007;236:217-26. [PMID: 17543437 DOI: 10.1016/j.tox.2007.04.012] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 4.8] [Reference Citation Analysis]